Cargando…
Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure
BACKGROUND: Hepatic encephalopathy (HE) is an important neuropsychiatry complication of acute-on-chronic liver failure (ACLF). PPI therapy may increase the intestinal bacterial overgrowth and infections. OBJECTIVES: The aim of this study was to assess whether PPI use in ACLF is associated with HE. P...
Autores principales: | Lin, Zhao-Ni, Zuo, Yong-Qing, Hu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989600/ https://www.ncbi.nlm.nih.gov/pubmed/24748895 http://dx.doi.org/10.5812/hepatmon.16258 |
Ejemplares similares
-
Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019) -
Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017) -
Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
por: Tantai, Xin-Xing, et al.
Publicado: (2019) -
Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis
por: Ma, Yun-Jie, et al.
Publicado: (2019) -
Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)